# Church & Dwight Co Inc: Form 10-Q for the period ended Sep 30, 2015

- Company: [Church & Dwight Co Inc](/companies/chd.md) (CIK 313927)
- Form: 10-Q
- Filed: 2015-11-02
- Accepted by EDGAR: Nov 2, 2015, 16:58 ET
- Period: 2015-09-30
- Accession: 0001564590-15-009064
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/313927/000156459015009064/chd-10q_20150930.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/313927/000156459015009064/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2015-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2015-07-01 to 2015-09-30 | $861.8m | us-gaap:SalesRevenueGoodsNet |
| Revenue | 9 months, 2015-01-01 to 2015-09-30 | $2.52bn | us-gaap:SalesRevenueGoodsNet |
| Cost of revenue | 3 months, 2015-07-01 to 2015-09-30 | $476.0m | us-gaap:CostOfGoodsSold |
| Cost of revenue | 9 months, 2015-01-01 to 2015-09-30 | $1.41bn | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months, 2015-07-01 to 2015-09-30 | $385.8m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2015-01-01 to 2015-09-30 | $1.11bn | us-gaap:GrossProfit |
| Research and development | 3 months, 2015-07-01 to 2015-09-30 | $16.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2015-01-01 to 2015-09-30 | $48.1m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2015-07-01 to 2015-09-30 | $102.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2015-01-01 to 2015-09-30 | $312.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2015-07-01 to 2015-09-30 | $190.6m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2015-01-01 to 2015-09-30 | $505.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2015-07-01 to 2015-09-30 | $7.4m | us-gaap:InterestExpense |
| Interest expense | 9 months, 2015-01-01 to 2015-09-30 | $22.9m | us-gaap:InterestExpense |
| Income tax | 3 months, 2015-07-01 to 2015-09-30 | $65.3m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2015-01-01 to 2015-09-30 | $169.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 9 months, 2015-01-01 to 2015-09-30 | $301.3m | us-gaap:ProfitLoss |
| Diluted EPS | 3 months, 2015-07-01 to 2015-09-30 | $0.90 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2015-01-01 to 2015-09-30 | $2.25 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2015-07-01 to 2015-09-30 | $0.92 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2015-01-01 to 2015-09-30 | $2.29 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2015-07-01 to 2015-09-30 | 133,600,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2015-01-01 to 2015-09-30 | 133,800,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2015-01-01 to 2015-09-30 | $408.8m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 9 months, 2015-01-01 to 2015-09-30 | $44.7m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months, 2015-01-01 to 2015-09-30 | $131.4m | us-gaap:PaymentsOfDividends |
| Share repurchases | 9 months, 2015-01-01 to 2015-09-30 | $263.1m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2015-09-30 | $210.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2015-09-30 | $851.7m | us-gaap:AssetsCurrent |
| Total assets | at 2015-09-30 | $4.22bn | us-gaap:Assets |
| Current liabilities | at 2015-09-30 | $783.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2015-09-30 | $2.17bn | us-gaap:Liabilities |
| Long-term debt | at 2015-09-30 | $706.0m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2015-09-30 | $250.0m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | at 2015-09-30 | $25.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2015-09-30 | $2.05bn | us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest |

## Management's discussion and analysis

As filed, 30,949 characters.

### RESULTS OF OPERATIONS

### Results of Operations

### Consolidated results

|  | Three Months Ended September 30, 2015 | Change vs. Prior Year | Three Months Ended September 30, 2014 |
| --- | ---: | ---: | ---: |
| **Net Sales** | **$861.8** | 2.4% | $841.8 |
| **Gross Profit** | **$385.8** | 5.0% | $367.5 |
| Gross Margin | **44.8%** | +110 basis points | 43.7% |
| **Marketing Expenses** | **$92.8** | -3.9% | $96.6 |
| Percent of Net Sales | **10.8%** | -70 basis points | 11.5% |
| **Selling, General & Administrative Expenses** | **$102.4** | 9.3% | $93.7 |
| Percent of Net Sales | **11.9%** | +80 basis points | 11.1% |
| **Income from Operations** | **$190.6** | 7.6% | $177.2 |
| Operating Margin | **22.1%** | +100 basis points | 21.1% |
|  | **Nine Months Ended** | **Change vs.** | **Nine Months Ended** |
|  | **September 30, 2015** | **Prior Year** | **September 30, 2014** |
| **Net Sales** | **$2,521.2** | 3.7% | $2,432.1 |
| **Gross Profit** | **$1,114.4** | 4.8% | $1,063.3 |
| Gross Margin | **44.2%** | +50 basis points | 43.7% |
| **Marketing Expenses** | **$297.4** | -0.1% | $297.8 |
| Percent of Net Sales | **11.8%** | -40 basis points | 12.2% |
| **Selling, General & Administrative Expenses** | **$312.0** | 8.3% | $288.1 |
| Percent of Net Sales | **12.4%** | +50 basis points | 11.9% |
| **Income from Operations** | **$505.0** | 5.8% | $477.4 |
| Operating Margin | **20.0%** | +40 basis points | 19.6% |

#### Net Sales

Net sales for the quarter ended September 30, 2015 were $861.8, an increase of $20.0 or 2.4% over the third quarter of 2014. Net sales for the nine months ended September 30, 2015 were $2,521.2, an increase of $89.1 or 3.7% over the comparable nine month period of 2014. The components of the net sales increase are as follows:

| Net Sales - Consolidated | Three Months Ended September 30, 2015 | Nine Months Ended September 30, 2015 |
| --- | ---: | ---: |
| Product volumes sold | 2.2% | 3.3% |
| Pricing/Product mix | 1.0% | 0.6% |
| Foreign exchange rate fluctuations | (3.1)% | (2.6)% |
| Volume from acquired product lines (1) | 2.3% | 2.4% |
| **Net Sales increase** | **2.4%** | **3.7%** |

(1) On September 19, 2014, the Company acquired certain brands in the Lil’ Drug Store Brands Acquisition (the “LDS Acquisition”) and on January 2, 2015, the Company acquired certain assets of Varied Industries Corporation (the “VI-COR Acquisition”). Net sales of these acquisitions are included in the Company’s results since the date of acquisition.

For the three months ended September 30, 2015, the volume change primarily reflects increased product sales in both the Consumer Domestic and Consumer International segments, with volume declines in Specialty Products (“SPD”). Favorable price/mix was recognized in Consumer Domestic and Consumer International. SPD realized the effect of lower prices. For the nine months ended September 30, 2015, volume increases and favorable price/mix were recognized in all three segments.

#### Gross Profit / Gross Margin

The Company’s gross profit was $385.8 for the quarter ended September 30, 2015, an $18.3 increase as compared to the same period in 2014. The Company’s gross profit was $1,114.4 for the nine months ended September 30, 2015, a $51.1 increase as compared to the same period in 2014. Gross margin increased 110 basis points (“bps”) in the third quarter of 2015 compared to the same period in 2014 due to 90 bps associated with higher volume, price and mix, favorable impact associated with the LDS and VI-COR Acquisitions of 40 bps, lower commodity costs of 80 bps, partially offset by higher manufacturing costs (net of productivity programs and including higher than anticipated start-up costs associated with the Company’s new vitamin manufacturing facility) of 60 bps and unfavorable foreign exchange rates of 40 bps. The higher volume, price and mix favorability included higher trade promotion and couponing to continue to support proven consumer trial generating activities for the OXICLEAN megabrand. Gross margin increased 50 bps to 44.2% in the first nine months of 2015 as compared to 43.7% in the same period of 2014. This is due to the favorable impact associated with the LDS and VI-COR Acquisitions of 50 bps, the impact of higher volume, price and product mix of 40 bps, lower commodity costs of 60 bps, partially offset by higher manufacturing costs (net of productivity programs and including start-up costs associated with the Company’s new vitamin manufacturing facility) of 70 bps and unfavorable foreign exchange rates of 30 bps.

#### Operating Expenses

Marketing expenses for the third quarter of 2015 were $92.8, a decrease of $3.8 or 3.9% as compared to the same period in 2014. Marketing expenses as a percentage of net sales decreased 70 bps to 10.8% in the third quarter of 2015 as compared to 11.5% in the same period in 2014 due to 30 bps from leverage of expenses on higher sales and 40 bps from a lower amount of marketing spending largely driven by shifting some marketing funds to trade promotion and couponing to continue to support proven consumer trial generating activities for the OXICLEAN megabrand. Marketing expenses for the first nine months of 2015 were $297.4, a decrease of $0.4 as compared to the same period in 2014. Marketing expenses as a percentage of net sales were 11.8% in the first nine months of 2015 as compared to 12.2% in the same period in 2014 all due to 40 bps from leverage of expenses on higher sales.

Selling, general and administrative (“SG&A”) expenses were $102.4 in the third quarter of 2015, an increase of $8.7 or 9.3% as compared to the same period in 2014 primarily due to higher compensation costs, higher information technology and research and development costs and both on-going and one-time costs associated with the LDS and VI-COR Acquisitions. SG&A as a percentage of net sales increased 80 bps to 11.9% in the third quarter of 2015 as compared to 11.1% in the same period in 2014. The increase is due to higher costs of 100 bps, partially offset by 20 bps of leverage associated with higher sales. SG&A for the first nine months of 2015 was $312.0, an increase of $23.9 as compared to the same period in 2014 due primarily to the same factors as those applicable to the third quarter of 2015 and an $8.9 pension settlement charge in the second quarter of 2015. SG&A as a percentage of net sales was 12.4% in the first nine months of 2015 as compared to 11.9% in the same period in 2014. The increase is due to the pension plan charge of approximately 40 bps and other cost increases of 50 bps, partially offset by 40 bps of leverage associated with higher sales.

#### Other Income and Expenses

Equity in earnings of affiliates for the three and nine month periods ended September 30, 2015 decreased by $0.3 and $16.3 respectively, as compared to the same periods in 2014. The decrease in the nine month earnings was due primarily to a $17.0 impairment charge associated with the Company’s remaining investment in Natronx recorded in the second quarter of 2015. This charge is primarily a result of lower than expected demand for the joint venture’s products as a result of a shift in the electric utility industry from coal-fired to natural gas-supplied power plants, continued delays in the implementation of updated federal regulations, and indirectly, the recent U.S. Supreme Court ruling against the Environmental Protection Agency (“EPA”) where the court stated that the EPA failed to properly consider the costs to implement the regulations. We believe that the foregoing factors will likely further delay the demand for these products.

Other expense for the three month period ended September 30, 2015 decreased $0.3 and increased $2.8 for the nine month period ended September 30, 2015, as compared to the same periods in 2014 due to the effect of changes in foreign currency rates.

Interest expense for the three and nine month periods ended September 30, 2015 increased $0.5 and $2.4, respectively, as compared to the same period in 2014 due to the higher debt outstanding to fund the LDS and VI-COR Acquisitions.

#### Income Taxes

The effective tax rate in the three and nine month periods ended September 30, 2015 was 35.2% and 36.0% respectively, compared to 33.1% and 33.9% respectively, in the same periods in 2014. The tax rate for the nine month period ended September 30, 2015 was negatively impacted by a valuation allowance recorded in connection with an impairment charge relating to the Company’s investment in a joint venture. The tax rate for the three and nine month periods ended September 30, 2014 was favorably impacted by discrete adjustments related to uncertain income tax positions.

### Segment results

The Company operates three reportable segments: Consumer Domestic, Consumer International and SPD. These segments are determined based on differences in the nature of products and organizational and ownership structures. The Company also has a Corporate segment.

| Segment | Products |
| --- | --- |
| Consumer Domestic | Household and personal care products |
| Consumer International | Primarily personal care products |
| SPD | Specialty chemical products |

The Corporate segment income consists of equity in earnings (losses) of affiliates. As of September 30, 2015, the Company held 50% ownership interests in each of Armand and ArmaKleen, respectively, and a one-third ownership interest in Natronx. The Company’s equity in earnings (losses) of Armand, ArmaKleen and Natronx for the three and nine month periods ended September 30, 2015 and September 30, 2014 are included in the Corporate segment. See Note 17 for a discussion of the impairment charge which is included in the Corporate segment.

Some of the subsidiaries that are included in the Consumer International segment manufacture and sell personal care products to the Consumer Domestic segment. These sales are eliminated from the Consumer International segment results set forth below.

Segment net sales and income before income taxes for the three and nine month periods ended September 30, 2015 and September 30, 2014 are as follows:

| Net Sales(1) | Consumer Domestic | Consumer International | SPD | Corporate(3) | Total |
| --- | ---: | ---: | ---: | ---: | ---: |
| **Third Quarter 2015** | **$656.4** | **$124.7** | **$80.7** | **$0.0** | **$861.8** |
| Third Quarter 2014 | 627.2 | 136.2 | 78.4 | 0.0 | 841.8 |
| **First Nine Months of 2015** | **$1,909.3** | **$376.0** | **$235.9** | **$0.0** | **$2,521.2** |
| First Nine Months of 2014 | 1,819.4 | 396.6 | 216.1 | 0.0 | 2,432.1 |
| **Income before Income Taxes(2)** |  |  |  |  |  |
| **Third Quarter 2015** | **$153.5** | **$16.3** | **$12.8** | **$3.1** | **$185.7** |
| Third Quarter 2014 | 141.4 | 15.0 | 13.4 | 3.4 | 173.2 |
| **First Nine Months of 2015** | **$395.8** | **$40.2** | **$42.9** | **$(8.4)** | **$470.5** |
| First Nine Months of 2014 | 376.0 | 47.5 | 33.5 | 7.9 | 464.9 |

(1) Intersegment sales from Consumer International to Consumer Domestic, which are not reflected in the table, were $0.9 and $0.3 for the three months ended September 30, 2015 and September 30, 2014, respectively, and were $3.9 and $0.8 for the nine months ended September 30, 2015 and September 30, 2014, respectively.

(2) In determining Income before Income Taxes, interest expense and investment earnings were allocated among the segments based upon each segment’s relative Income from Operations.

(3) Corporate segment consists of equity in earnings (losses) of affiliates from Armand, ArmaKleen and Natronx.

Product line revenues from external customers are as follows:

|  | Three Months Ended September 30, 2015 | September 30, 2014 | Nine Months Ended September 30, 2015 | September 30, 2014 |
| --- | ---: | ---: | ---: | ---: |
| Household Products | **$391.2** | $379.5 | **$1,148.6** | $1,087.2 |
| Personal Care Products | **265.2** | 247.7 | **760.7** | 732.2 |
| Total Consumer Domestic | **656.4** | 627.2 | **1,909.3** | 1,819.4 |
| Total Consumer International | **124.7** | 136.2 | **376.0** | 396.6 |
| Total SPD | **80.7** | 78.4 | **235.9** | 216.1 |
| **Total Consolidated Net Sales** | **$861.8** | $841.8 | **$2,521.2** | $2,432.1 |

Household Products include laundry, deodorizing, and cleaning products. Personal Care Products include condoms, pregnancy kits, oral care products, skin care products and gummy dietary supplements.

### Consumer Domestic

Consumer Domestic net sales in the third quarter of 2015 were $656.4, an increase of $29.2 or 4.7% as compared to the same period in 2014. Consumer Domestic net sales for the nine months ended September 30, 2015 were $1,909.3, an increase of $89.9 or 4.9% as compared to the same period in 2014. The components of the net sales change are the following:

| Net Sales - Consumer Domestic | Three Months Ended September 30, 2015 | Nine Months Ended September 30, 2015 |
| --- | ---: | ---: |
| Product volumes sold | 1.6% | 2.4% |
| Pricing/Product mix | 1.2% | 0.6% |
| Volume from acquired product lines (1) | 1.7% | 1.7% |
| Other | 0.2% | 0.2% |
| **Net Sales increase** | **4.7%** | **4.9%** |

(1) Includes net sales of the brands acquired in the LDS Acquisition since the date of acquisition.

Other than sales from the LDS Acquisition, the increase in net sales for the three month period ending September 30, 2015, reflects higher sales for the ARM & HAMMER CLUMP & SEAL cat litter product lines including the new lightweight variant launched in December 2014, ARM & HAMMER liquid laundry detergent, gummy dietary supplements and BATISTE dry shampoo. For the nine month period, higher sales of ARM & HAMMER CLUMP & SEAL cat litter, ARM & HAMMER liquid laundry detergent, and BATISTE dry shampoo were offset by lower sales of gummy dietary supplements, TROJAN condoms and XTRA laundry detergent.

Since the 2012 introduction in the U.S. of unit dose laundry detergent by various manufacturers, including the Company, there has been significant product and price competition in the laundry detergent category, contributing to an overall category decline. In 2014, the Procter & Gamble Company, one of the Company’s major competitors and the market leader in laundry detergent, took several competitive actions, including launching a lower-priced line of laundry detergents that competes directly with the Company’s core value laundry detergents. In the first quarter of 2015, the competitive environment intensified as Henkel AG & Co. KGaA entered the U.S. market in two retailers with Persil, its leading premium laundry detergent around the world and is now expanding nationally in the U.S. While it is too early to assess what impact this will have on the premium laundry category or the Company’s laundry detergent business, the introduction of Persil could precipitate greater price competition in the category with a potential adverse impact on OXICLEAN laundry detergent. The Company continues to evaluate and vigorously combat the pressures in the laundry detergent category through, among other things, new product introductions and increased marketing spending. Despite the category being flat for the last twelve months and recent category growth in both the second and third quarters of 2015, after declines in 2013 and 2014, there is no assurance the category will not decline and that the Company will be able to offset any such category decline.

Additionally, delays in the Company’s second quarter start-up of the new vitamin manufacturing facility have resulted in the need to place certain retailers on allocation, which has led to increased retailer scrutiny of our products. Production rates are increasing and we continue to take measures to improve and have improved customer service levels and product quality and appearance, including utilizing outside suppliers on a limited basis. If, however, the Company were to lose a significant customer or if sales of its vitamin products were to materially decrease due to customer service levels or real or perceived product quality or appearance issues, it could have a material adverse effect on the Company’s business, financial condition and results of operations.

Consumer Domestic income before income taxes for the third quarter of 2015 was $153.5, a $12.1 increase as compared to the third quarter of 2014. The increase is due primarily to the impact of higher sales volumes of $13.2 and favorable price/mix of $7.4, partially offset by higher SG&A costs of $10.2. Higher manufacturing costs, which includes vitamin manufacturing start-up costs, were offset by productivity programs and lower commodity costs. For the nine month period ended September 30, 2015, income before income taxes was $395.8, a $19.8 increase as compared to the first nine months of 2014. The increase is due primarily to the impact of higher sales volumes of $45.8 and favorable price/mix of $6.6, partially offset by higher SG&A costs of $20.8, higher marketing costs of $2.0 and higher manufacturing costs of $8.8 (including the vitamin manufacturing start-up costs offset by productivity programs and lower commodity costs).

### Consumer International

Consumer International net sales were $124.7 in the third quarter of 2015, a decrease of $11.5 or 8.4% as compared to the same period in 2014. Consumer International net sales for the nine months ended September 30, 2015 were $376.0, a decrease of $20.6 or approximately 5.2% as compared to the same period in 2014. The components of the net sales change are the following:

| Net Sales - Consumer International | Three Months Ended September 30, 2015 | Nine Months Ended September 30, 2015 |
| --- | ---: | ---: |
| Product volumes sold | 6.9% | 8.1% |
| Pricing/Product mix | 1.0% | 0.9% |
| Foreign exchange rate fluctuations / Other | (17.5)% | (15.5)% |
| Volume from acquired product lines (1) | 1.2% | 1.3% |
| **Net Sales (decrease )** | **(8.4)%** | (5.2)% |

(1) Includes net sales of the brands acquired in the LDS Acquisition since the date of acquisition.

Excluding the impact of unfavorable foreign exchange rates, higher sales in the third quarter of 2015 occurred in substantially all of the countries in which Consumer International operates, but most significantly in Australia, Canada, Europe and Mexico, as well as increased U.S. exports. Higher sales in the first nine months of 2015 occurred in all countries in which Consumer International operates.

Consumer International income before income taxes was $16.3 in the third quarter of 2015, an increase of $1.3 compared to the same period in 2014 due primarily to higher volumes of $5.2 and favorable price/mix of $1.5, partially offset by unfavorable foreign exchange rates of $4.1 and higher SG&A of $1.1. For the first nine months of 2015, income before income taxes was $40.2, a $7.3 decrease as compared to the same period of 2014, due primarily to an $8.9 pension settlement charge recorded in the second quarter of 2015, the impact of unfavorable exchange rates of $15.0 and higher marketing costs of $4.8, partially offset by higher volumes of $18.2 and favorable price/mix of $2.7.

### Specialty Products (“SPD”)

SPD net sales were $80.7 for the third quarter of 2015, an increase of $2.3 or 2.9% as compared to the same period in 2014. SPD net sales for the nine months ended September 30, 2015 were $235.9, an increase of $19.8, or 9.2% as compared to the same period of 2014. The components of the net sales change are the following:

| Net Sales - SPD | Three Months Ended September 30, 2015 | Nine Months Ended September 30, 2015 |
| --- | ---: | ---: |
| Product volumes sold | (1.4)% | 1.6% |
| Pricing/Product mix | (0.8)% | 0.8% |
| Foreign exchange rate fluctuations / Other | (4.3)% | (3.2)% |
| Volume from acquired product lines (1) | 9.4% | 10.0% |
| **Net Sales increase** | **2.9%** | **9.2%** |

(1) Net sales of the VI-COR Acquisition are included in the Company’s results since the date of acquisition.

The net sales increase in the third quarter of 2015 reflects higher sales in the chemicals business and the VI-COR animal nutrition acquisition, partially offset by lower sales in the existing animal nutrition business. The increase in net sales for the nine months ended September 30, 2015 is due primarily to the same factors as those applicable to the third quarter of 2015.

SPD income before income taxes was $12.8 in the third quarter of 2015, a decrease of $0.6 as compared to the same period in 2014 due primarily to unfavorable foreign exchange rates of $4.1, higher SG&A of $2.9 and unfavorable price/mix of $0.6, partially offset by higher volumes of $4.5 and lower commodity costs of $2.8. For the first nine months of 2015, income before income taxes was $42.9, an increase of $9.4 as compared to the same period in 2014, due primarily to higher sales volume of $14.7, lower manufacturing costs of $8.7 and favorable price/mix of $1.6, partially offset by unfavorable foreign currency rates of $7.2, higher SG&A of $6.5 and higher marketing expenses of $1.4.

### Corporate

The administrative costs of the Company’s production, planning and logistics functions are included in the SG&A expenses of each operating segment and as elements of cost of sales in the Company’s Consolidated Statements of Income. The Corporate segment includes equity in earnings (losses) of affiliates from Armand, ArmaKleen and Natronx. The Corporate segment income before income taxes was $3.1 in the third quarter of 2015, a decrease of $0.3 as compared to the same period in 2014. The Corporate segment income before income taxes was a loss of $8.4 for the first nine months of 2015, a decrease of $16.3 as compared to the same period in 2014 due to the $17.0 Natronx impairment charge recorded in the second quarter of 2015.

### Liquidity and capital resources

As of September 30, 2015, the Company had $210.6 in cash and cash equivalents, approximately $570.0 available through the revolving facility under its principal credit agreement (the “Credit Agreement”) and its commercial paper program, and a commitment increase feature under the Credit Agreement that enables the Company to borrow up to an additional $500.0, subject to lending commitments of the participating lenders and certain conditions as described in the Credit Agreement. To preserve its liquidity, the Company invests its cash primarily in prime money market funds and short term bank deposits.

During the second quarter of 2015, the Company liquidated its subsidiary in the Netherlands and decided that the earnings of its subsidiary in France would no longer be permanently reinvested outside of the U.S. As a result, the Company repatriated cash of $93.0. The funds repatriated were used to reduce outstanding commercial paper. As a result of liquidating its subsidiary in the Netherlands, the Company recorded a tax benefit of $2.7 in the Consolidated Statement of Income and a deferred tax benefit of $11.6 recorded through Accumulated Other Comprehensive Income in the second quarter of 2015. As of September 30, 2015, there remains $142.2 of cash and cash equivalents outside the U.S. These funds are not needed for operations in the U.S. If they were, the Company would be required to accrue and pay taxes in the U.S. to repatriate these funds. The Company’s intent is to permanently reinvest these funds outside the U.S., and the Company does not currently expect to repatriate them to fund U.S. operations.

The current economic environment presents risks that could have adverse consequences for the Company’s liquidity. (See “Unfavorable economic conditions could adversely affect demand for the Company’s products” under “Risk Factors” in Item 1A of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2014 (the “Form 10-K”).) The Company does not anticipate that current economic conditions will adversely affect its ability to comply with the financial covenant in the Credit Agreement because the Company currently is, and anticipates that it will continue to be, in compliance with the maximum leverage ratio requirement under the Credit Agreement.

On January 28, 2015, the Board declared an 8% increase in the regular quarterly dividend from $0.31 to $0.335 per share, equivalent to an annual dividend of $1.34 per share as of February 10, 2015. The decision raised the annual dividend payout from $168.0 to approximately $175.0. The Company has an objective of distributing 40% of its net income. In 2015, the Company’s distribution was higher than its target.

On January 29, 2014, the Company authorized an evergreen share repurchase program to reduce or eliminate dilution associated with the issuance of Common Stock under the Company’s incentive plans. As part of the evergreen share repurchase program, in January 2015, the Company repurchased 0.5 million shares at a cost of $41.2. On January 28, 2015, the Board authorized a share repurchase program under which the Company may repurchase up to $500.0 in shares of Common Stock (the “2015 Share Repurchase Program”). In February 2015, the Company entered into an accelerated share repurchase contract with a commercial bank to repurchase 2.6 million shares of Common Stock at a cost of $215.0, of which approximately $47.0 was purchased under the evergreen share repurchase program and approximately $168.0 was purchased under the 2015 Share Repurchase Program. On April 24, 2015, the settlement date, the Company issued 83 thousand shares of Common Stock to the commercial bank in a private transaction for approximately $7.0 to settle the accelerated share repurchase contract. On May 18, 2015, the Company repurchased the 83 thousand shares from the commercial bank for approximately $7.0 pursuant to the terms of the accelerated share repurchase contract.

The Company anticipates that its available cash and cash from operations will be sufficient to meet its capital expenditure program costs, which are expected to be a total of approximately $70.0 in 2015, fund the 2015 Share Repurchase Program and the evergreen share repurchase program to the extent implemented by management, pay dividends at the latest approved rate and fund cash contributions to benefit plans. Cash, together with the Company’s current borrowing capacity, may be used for acquisitions that would complement the Company’s existing product lines or geographic markets.

The Company also anticipates that it will generate sufficient cash from operations during the remainder of 2015 that combined with a portion of its existing cash balance and its commercial paper program, will enable the Company to fully repay the $250.0 of 3.35% Senior Notes due on December 15, 2015.

#### Net Debt

The Company had outstanding total debt of $981.0 and cash of $210.6, resulting in net debt of $770.4 at September 30, 2015. This compares to total debt of $1,095.2 and cash of $423.0, resulting in net debt of $672.2 at December 31, 2014. Net debt is defined as the sum of short-term debt and long-term debt, minus cash and cash equivalents.

#### Cash Flow Analysis

|  | Nine Months Ended September 30, 2015 | September 30, 2014 |
| --- | ---: | ---: |
| Net cash provided by operating activities | **$408.8** | $408.7 |
| Net cash used in investing activities | **$(122.6)** | $(253.6) |
| Net cash used in financing activities | **$(480.3)** | $(271.6) |

**Net Cash Provided by Operating Activities –** The Company’s primary source of liquidity is the strong cash flow provided by operating activities, which is dependent on the level of net income and changes in working capital. The Company’s net cash provided by operating activities in the nine months ended September 30, 2015 increased by $0.1 to $408.8 as compared to the same period in 2014 due to higher cash earnings (net income plus non-cash expenses such as depreciation, amortization, non-cash compensation and asset impairment charges) offset by higher working capital. The increase in working capital is primarily due to higher accounts receivable and inventory in support of higher sales, partially offset by lower tax payments due to timing. However, the Company measures working capital effectiveness based on its cash conversion cycle. The Company's cash conversion cycle, (defined as days in accounts receivable plus days in inventory less days in accounts payable) which is calculated using a 2 quarter average method, improved 4 days from the prior year amount of 35 days to 31 days at September 30, 2015 due primarily to improved accounts payable of 4 days. Accounts receivable which improved by 1 day to 35 was offset by a 1 day increase in inventory. The improvement in the Company's cash conversion cycle reflects the Company's continued focus on reducing its average working capital requirements.

**Net Cash Used in Investing Activities –** Net cash used in investing activities during the first nine months of 2015 was $122.6, principally reflecting $74.9 for the VI-COR Acquisition and $44.7 for property, plant and equipment expenditures, in large part due to the Company’s new gummy vitamin manufacturing facility in York, Pennsylvania. Net cash used in investing activities during the first nine months of 2014 was $253.6, principally reflecting the $216.1 paid for the Lil’ Drug Store Brands Acquisition, and $36.2 for property, plant and equipment expenditures.

**Net Cash Used in Financing Activities –** Net cash used in financing activities during the first nine months of 2015 was $480.3, primarily reflecting $263.1 of repurchases of Common Stock, $131.4 of cash dividend payments, repayment of $118.3 of commercial paper borrowings and $3.4 of short term borrowings at an international subsidiary, offset by $36.9 of proceeds and tax benefits from stock option exercises. Net cash used in financing activities during the first nine months of 2014 was $271.6, primarily reflecting $435.0 of repurchases of Common Stock, $126.0 of cash dividends offset by an increase in short-term debt of $250.4 to fund the Lil’ Drug Store Brands Acquisition and $39.1 of proceeds and tax benefits from stock option exercises.

### Financial Covenant

“Consolidated EBITDA” (referred to below as “Adjusted EBITDA” and defined in the Credit Agreement that was revised in December 2014) is a component of the financial covenant contained in the Credit Agreement. The financial covenant includes a leverage ratio (total debt to Adjusted EBITDA), which, if not met, could result in an event of default and trigger the early termination of the Credit Agreement. Adjusted EBITDA may not be comparable to similarly titled measures used by other entities and should not be considered as an alternative to cash flows from operating activities determined in accordance with accounting principles generally accepted in the U.S. The Company’s leverage ratio for the twelve months ended September 30, 2015 was 1.32, which is below the maximum of 3.75 permitted under the Credit Agreement.

## Market risk

As filed, 3,627 characters.

### Market risk

#### Interest Rate Risk

The Company had outstanding total debt at September 30, 2015 of $981.0, of which 97% has a fixed weighted average interest rate of 2.87% and the remaining 3% constituted principally commercial paper issued by the Company that currently has a weighted average interest rate of less than 0.5%. In December 2014, the Company entered into interest rate swap agreements on an aggregate notional amount of $300.0 to convert the fixed interest rate on the 2.45% Senior Notes due in 2019 to a variable interest rate based on LIBOR.

#### Diesel Fuel Hedges

The Company uses independent freight carriers to deliver its products. These carriers currently charge the Company a basic rate per mile for diesel fuel price increases. During 2014 and 2015, the Company entered into hedge agreements with financial counterparties to mitigate the volatility of diesel fuel prices, and not to speculate in the future price of diesel fuel. Under the hedge agreements, the Company agreed to pay a fixed price per gallon of diesel fuel determined at the time the agreements were executed and to receive a floating rate payment that is determined on a monthly basis based on the average price of the Department of Energy’s Diesel Fuel Index during the applicable month and is designed to offset any increase or decrease in fuel costs that the Company pays to its common carriers. The agreements are expected to cover approximately 72% of the Company’s remaining 2015 diesel fuel requirements and approximately 32% of the Company’s estimated diesel fuel requirements for 2016. These diesel fuel hedge agreements qualify for hedge accounting. Therefore, changes in the fair value of such agreements are recorded under Accumulated Other Comprehensive Income on the balance sheet.

#### Foreign Currency

The Company is subject to exposure from fluctuations in foreign currency exchange rates, primarily U.S. Dollar/Euro, U.S. Dollar/British Pound, U.S. Dollar/Canadian Dollar, U.S. Dollar/Mexican Peso, U.S. Dollar/Australian Dollar, U.S. Dollar/Brazilian Real and U.S. Dollar/Chinese Yuan.

The Company enters into forward exchange contracts to reduce the impact of foreign exchange rate fluctuations related to anticipated but not yet committed sales or purchases denominated in U.S. Dollar, Canadian Dollar, British Pound and Euro. The Company entered into forward exchange contracts to protect itself from the risk that, due to changes in currency exchange rates, it would be adversely affected by net cash outflows. The face value of the unexpired contracts as of September 30, 2015 was $165.7, of which $123.6 qualify as foreign currency cash flow hedges and, therefore, changes in the fair value of the contracts are recorded in Other Comprehensive Income (Loss) and reclassified to earnings when the hedged transactions affect earnings. The agreements cover almost all of the expected intercompany purchases made by the Company’s Canadian subsidiary for the balance of 2015 and 2016.

#### Equity Derivatives

The Company has entered into equity derivative contracts covering its stock in order to minimize the liability resulting from changes in the quoted fair values of such stock to participants in its Executive Deferred Compensation Plan who have investments under that Plan in a notional Company stock fund. These equity derivative contracts are typically settled in cash. Since the equity derivatives do not qualify for hedge accounting, the Company is required to mark the contracts to market throughout the life of the contracts and record changes in fair value in the consolidated statement of income.

## Controls and procedures

As filed, 5,326 characters.

a) Evaluation of Disclosure Controls and Procedures

The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) at the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures, as of the end of the period covered by this report, are effective to provide reasonable assurance that the information required to be disclosed by the Company in reports filed under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the rules and forms of the United States Securities and Exchange Commission (the “Commission”), and (ii) accumulated and communicated to the Company’s management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding the disclosure.

b) Change in Internal Control over Financial Reporting

No change in the Company’s internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the Company’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

### CAUTIONARY NOTE ON FORWARD-LOOKING INFORMATION

This report contains forward-looking statements, including, among others, statements relating to sales and earnings growth; the effect of product mix; volume growth, including the effects of new product launches into new and existing categories; the impact of unit dose laundry detergent; the effects of competition; gross margin changes including the vitamin manufacturing start-up costs; trade and marketing spending; marketing expense as a percentage of net sales; cost savings programs; the Company’s hedge programs; the impact of foreign exchange and commodity price fluctuations; the impact of a pension settlement charge; the Company’s share repurchase programs; the impact of acquisitions; capital expenditures; the effective tax rate; tax changes; environmental and regulatory matters; the effect of the credit environment on the Company’s liquidity and capital expenditures; the Company’s fixed rate debt; compliance with covenants under the Company’s Credit Agreement and other debt instruments; the Company’s commercial paper program; sufficiency of cash flows from operations; the Company’s cash conversion cycle; the Company’s current and anticipated future borrowing capacity to meet capital expenditure program costs; payment of dividends; actual and expected cash contributions to pension plans; investments in the Natronx Technologies, LLC joint venture; availability and adequacy of raw materials; and the ability to manage and maintain key customer relationships. These statements represent the intentions, plans, expectations and beliefs of the Company, and are based on assumptions that the Company believes are reasonable but may prove to be incorrect. In addition, these statements are subject to risks, uncertainties and other factors, many of which are outside the Company’s control and could cause actual results to differ materially from such forward-looking statements. Factors that might cause such differences include a decline in market growth, retailer distribution and consumer demand (as a result of, among other things, political, economic and marketplace conditions and events); unanticipated increases in raw material and energy prices; adverse developments affecting the financial condition of major customers and suppliers; competition, including The Procter & Gamble Company’s participation in the value laundry detergent category and Henkel AG & Co. KGaA’s entrance into the U.S. laundry detergent market with Persil, its leading premium laundry detergent around the world; changes in marketing and promotional spending; growth or declines in various product categories and the impact of customer actions in response to changes in consumer demand and the economy, including increasing shelf space of private label products; consumer and competitor reaction to, and customer acceptance of, new product introductions and features; our ability to maintain product quality at a level acceptable to consumers; disruptions in the banking system and financial markets; foreign currency exchange rate fluctuations; the impact of natural disasters on the Company and its customers and suppliers, including third party information technology service providers; the acquisition or divestiture of assets; the outcome of contingencies, including litigation, pending regulatory proceedings and environmental matters; and changes in the regulatory environment.

The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by the U. S. federal securities laws. You are advised, however, to consult any further disclosures the Company makes on related subjects in its filings with the Commission.

## Risk factors

As filed, 2,634 characters.

In addition to the other information set forth in this report, you should carefully consider the factors discussed in Item 1A, “Risk Factors” in the Form 10-K, which could materially affect the Company’s business, financial condition or future results. Other than the risk described below, there were no material changes in risk factors for the Company in the period covered by this report.

- **Cost overruns and delays, regulatory requirements, and miscalculations in capacity needs with respect to the Company’s expansion projects could adversely affect its business.**

The Company initiates expansion projects from time to time. For example, in 2014 and the first quarter of 2015, the Company expanded its gummy dietary supplements production capacity at its York, Pennsylvania manufacturing facility to meet expected future product demand. The new gummy dietary supplements started production in the second quarter of 2015. Projects of this type are subject to risks of delay or cost overruns inherent in any large construction project resulting from numerous factors, including the following: shortages of equipment, materials or skilled labor; work stoppages; unscheduled delays in the delivery of ordered materials and equipment; unanticipated cost increases; difficulties in obtaining necessary permits or in meeting permit conditions; difficulties in meeting regulatory requirements or obtaining regulatory approvals; availability of suppliers to certify equipment for existing and enhanced regulations; design and engineering problems; and failure or delay of third party service providers, civil unrest and labor disputes. Significant cost overruns or delays in completing a project, or the miscalculations of our anticipated capacity needs, could have a material adverse effect on the Company’s return on investment, results of operations and cash flows. In the second quarter of 2015, delays in the Company’s start-up of the new vitamin manufacturing facility resulted in the need to place certain retailers on allocation, which contributed to increased retailer frustration with and scrutiny of our products. Although the Company has continued to take measures to improve, and has improved, customer service levels and product quality and appearance, these initiatives may not be successful. If the Company were to lose a significant customer, or if sales of its vitamin products were to materially decrease due to customer service levels or real or perceived product quality or appearance issues, this could also have a material adverse effect on the Company’s business, financial condition and results of operations.

Filed Nov 2, 2015.
Source: SEC EDGAR, the filing index for accession 0001564590-15-009064. Last ingested by Listed: Nov 14, 2026, 21:34 ET. No prices; not investment advice.
